BMJ 2001;322:1249 ( 19 May )

Letters

Marketing studies and scientific research must be distinct

The first 150 words of the full text of this article appear below.

EDITOR---Drew and Davies's trial to assess the effectiveness of Ginkgo biloba in tinnitus, which was conducted by post and telephone, raises several important methodological issues.1 The advantages of such a design are obvious: easy and quick recruitment of patients allowing large sample sizes at comparatively low costs. The disadvantages are exemplified by the study's limitations.1

As there was no doctor-patient contact the exact diagnoses are not certain, and the outcome measures depict only perceived effects. External monitoring and quality control were impossible, which means that the quality and reliability of the rough data are questionable. The patients' general practitioners could probably not be informed, and serious adverse events or drug interactions were impossible to assess. Ginkgo biloba has antiplatelet activity2 and thus can lead to serious bleeding---for example, haemorrhagic stroke---and an increase in bleeding tendency when taken concomitantly with oral anticoagulants. 3 4

The question is whether the . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial
Shelley Drew and Ewart Davies
BMJ 2001 322: 73. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Proportionality and objective evidence please
Ron Law
bmj.com, 18 May 2001 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ